Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens-Reference-Cited by-同舟云学术

Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens

Published:2022-04-18 Issue:9 Volume:82 Page:993-1002
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Yuen Kobe C.¹,Tran Ben²³,Anton Angelyn³⁴,Hamidi Habib¹,Costello Anthony J.⁵⁶⁷,Corcoran Niall M.⁵⁶,Lawrentschuk Nathan³⁵⁶,Rainey Natalie³,Semira Marie C. G.³,Gibbs Peter³,Mariathasan Sanjeev¹,Sandhu Shahneen²,Kadel Edward E.¹^ORCID

Affiliation:

1. Department of Oncology Biomarker Development Genentech, Inc. South San Francisco California USA

2. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia

3. Walter and Eliza Hall Institute of Medical Research Melbourne Victoria Australia

4. Eastern Health Melbourne Victoria Australia

5. Royal Melbourne Hospital Melbourne Victoria Australia

6. Department of Surgery The University of Melbourne Melbourne Victoria Australia

7. Australian Prostate Centre North Melbourne Victoria Australia

Funder

Genentech

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24346

Reference38 articles.

1. Treatment of Advanced Prostate Cancer

2. Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance

3. Immune Infiltration and Prostate Cancer

4. Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).

5. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RTK–RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/FUS::ERG;Blood Science;2024-04

2. Comprehensive genomic profiling testing in Japanese castration-resistant prostate cancer patients: results of a single-center retrospective cohort study;Japanese Journal of Clinical Oncology;2023-10-28